ARE THERE CHANGES IN SENSITIVITY TO 5-HT3 RECEPTOR LIGANDS FOLLOWING CHRONIC DIAZEPAM TREATMENT

被引:29
作者
ANDREWS, N [1 ]
FILE, SE [1 ]
机构
[1] UNITED MED & DENT SCH GUYS & ST THOMAS HOSP,GUYS HOSP,DIV PHARMACOL,PSYCHOPHARMACOL RES UNIT,LONDON SE1 9RT,ENGLAND
基金
英国惠康基金;
关键词
BENZODIAZEPINE; DEPENDENCE; ANXIETY; 5-HT3; ZACOPRIDE;
D O I
10.1007/BF02245120
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Administration of 1-(3-chlorophenyl)-biguanide (mCPB), a 5-HT3 receptor agonist (1 and 10 mg/kg IP), was found to be significantly anxiogenic in vehicle treated rats tested in the plus-maze, while having no significant effect in rats withdrawn for 24 h from 21 days diazepam treatment (2 mg/kg/day), suggesting a decreased agonist action at 5-HT3 receptors following withdrawal from chronic diazepam treatment. In the social interaction test, diazepam withdrawn rats showed a significant decrease in social interaction when compared to the chronic vehicle treated group. This anxiogenic response was reversed by low doses of zacopride (0.0001-0.01 mg/kg IP); in the vehicle treated animals 0.1 mg/kg was significantly anxiogenic. The overall pattern of results with zacopride is explained by suggesting that the anxiogenic effects of high doses of zacopride are detectable at low levels of 5-HT function and are due to an agonist action of the S-isomer in the rat at 5-HT3 receptors. The anxiolytic action of low doses is attributed to the R-isomer acting at the R-zacopride binding site and is enhanced in conditions of high 5-HT function, e.g. in the diazepam withdrawn rats. If this hypothesis is correct, then we would predict the R-isomer alone would be more effective in reversing the anxiogenic effects of diazepam withdrawal than the racemate, used here.
引用
收藏
页码:333 / 337
页数:5
相关论文
共 27 条
[1]  
ANDREWS MA, 1992, IN PRESS PHARM BIOCH
[2]   THE DIFFERENTIAL ACTIVITIES OF R(+)-ZACOPRIDE AND S(-)-ZACOPRIDE AS 5-HT3 RECEPTOR ANTAGONISTS [J].
BARNES, JM ;
BARNES, NM ;
COSTALL, B ;
DOMENEY, AM ;
JOHNSON, DN ;
KELLY, ME ;
MUNSON, HR ;
NAYLOR, RJ ;
YOUNG, R .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1990, 37 (04) :717-727
[3]   [H-3] ZACOPRIDE - LIGAND FOR THE IDENTIFICATION OF 5-HT3 RECOGNITION SITES [J].
BARNES, NM ;
COSTALL, B ;
NAYLOR, RJ .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1988, 40 (08) :548-551
[4]   PRELIMINARY EVIDENCE FOR THE INVOLVEMENT OF THE PUTATIVE 5-HT4 RECEPTOR IN ZACOPRIDE-INDUCED AND COPPER SULFATE-INDUCED VOMITING IN THE FERRET [J].
BHANDARI, P ;
ANDREWS, PLR .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1991, 204 (03) :273-280
[5]   (-) BACLOFEN DECREASES NEUROTRANSMITTER RELEASE IN THE MAMMALIAN CNS BY AN ACTION AT A NOVEL GABA RECEPTOR [J].
BOWERY, NG ;
HILL, DR ;
HUDSON, AL ;
DOBLE, A ;
MIDDLEMISS, DN ;
SHAW, J ;
TURNBULL, M .
NATURE, 1980, 283 (5742) :92-94
[6]   ACTIVATION OF 5-HT3 RECEPTOR BY 1-PHENYLBIGUANIDE INCREASES DOPAMINE RELEASE IN THE RAT NUCLEUS-ACCUMBENS [J].
CHEN, J ;
VANPRAAG, HM ;
GARDNER, EL .
BRAIN RESEARCH, 1991, 543 (02) :354-357
[7]   EFFECTS OF THE 5-HT3 RECEPTOR ANTAGONIST, GR38032F, ON RAISED DOPAMINERGIC ACTIVITY IN THE MESOLIMBIC SYSTEM OF THE RAT AND MARMOSET BRAIN [J].
COSTALL, B ;
DOMENEY, AM ;
NAYLOR, RJ ;
TYERS, MB .
BRITISH JOURNAL OF PHARMACOLOGY, 1987, 92 (04) :881-894
[8]   ZACOPRIDE - ANXIOLYTIC PROFILE IN RODENT AND PRIMATE MODELS OF ANXIETY [J].
COSTALL, B ;
DOMENEY, AM ;
GERRARD, PA ;
KELLY, ME ;
NAYLOR, RJ .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1988, 40 (04) :302-305
[9]   THE EFFECTS OF ONDANSETRON (GR38032F) IN RATS AND MICE TREATED SUBCHRONICALLY WITH DIAZEPAM [J].
COSTALL, B ;
JONES, BJ ;
KELLY, ME ;
NAYLOR, RJ ;
OAKLEY, NR ;
ONAIVI, ES ;
TYERS, MB .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1989, 34 (04) :769-778
[10]   PATTERNS OF BENZODIAZEPINE USE IN GREAT-BRITAIN AS MEASURED BY A GENERAL-POPULATION SURVEY [J].
DUNBAR, GC ;
PERERA, MH ;
JENNER, FA .
BRITISH JOURNAL OF PSYCHIATRY, 1989, 155 :836-841